Write down short notes on Simeltegnosia

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File

Simultanagnosia — Short Notes

Definition: A visual-perceptual deficit in which a patient cannot perceive more than one object (or more than one element of a complex scene) at a time, despite being able to see individual objects normally. The patient "sees the trees but misses the forest" - e.g., shown a table lamp, they may focus on the circular base and call it an ashtray.
Core mechanism: A deficit of visual-spatial binding/integration - the inability to combine foveal (central gaze) information with peripheral visual information into a coherent whole. Patients can perceive only one small region of the visual field at a time, and this region shifts unpredictably, so objects may seem to "vanish" suddenly (failure to compute oculomotor return after a saccade).
Clinical features:
  • Difficulty scanning complex visual scenes or identifying moving objects
  • Describes isolated fragments of a picture rather than the whole scene
  • Movement and distracting stimuli make the deficit worse
  • Considered the "opposite" of static visual (object) agnosia
Associated syndrome - Balint's syndrome: Simultanagnosia is the core/cardinal feature of Balint's syndrome, a triad caused by bilateral lesions of the dorsolateral parieto-occipital (posterior parietal) association cortex:
  1. Simultanagnosia
  2. Optic ataxia (impaired visually-guided reaching, with intact proprioceptive-guided reaching - distinguishes it from cerebellar ataxia)
  3. Oculomotor (ocular) apraxia (impaired voluntary scanning eye movements)
Simultanagnosia can occur in isolation, without the other two components, particularly in posterior cortical atrophy (an atypical, visual-predominant presentation of Alzheimer's disease) - seen in up to 88% of PCA cases at diagnosis.
Causes: Bilateral parieto-occipital lesions from watershed (border-zone) infarction, CVA, head injury, neoplasm, or neurodegeneration (posterior cortical atrophy/atypical AD).
Bedside testing: A modified letter-cancellation task is used - large targets (7.5-10 cm) are mixed among small foil letters (2.5 cm) on a page. Patients with simultanagnosia characteristically miss the larger targets, because identifying a large letter requires integrating visual information across multiple fixation points (multiple foveations), which they cannot do - this confirms the deficit is central/integrative rather than due to poor visual acuity.
Related but distinct entities (same network):
  • Hemispatial neglect
  • Dressing apraxia (failure to align body axis with garment axis)
  • Constructional apraxia (difficulty copying line drawings)
  • Route-finding/navigational impairment
Sources: Harrison's Principles of Internal Medicine, 22nd ed.; Bradley and Daroff's Neurology in Clinical Practice; Neuroanatomy through Clinical Cases, 3rd ed.
Note on spelling: The standard medical term is simultanagnosia (also written "simultagnosia"); "Simeltegnosia" appears to be a misspelling of this term.

How would you clinically distinguish simultanagnosia from optic ataxia?

Finding Sources

Simultanagnosia vs. Optic Ataxia — Clinical Distinction

Both are components of Balint's syndrome (bilateral dorsolateral parieto-occipital lesions), but they test different functions and are distinguished at the bedside as follows:
FeatureSimultanagnosiaOptic Ataxia
What is impairedPerception - integrating multiple elements of a visual scene into a coherent wholeAction - visually-guided reaching/pointing toward an object
Core deficitCan only perceive one object/element at a time; loses the "big picture" while individual parts are seen fineCan perceive the object accurately but cannot direct the hand to it under visual guidance
Bedside testShow a complex picture or scene (e.g., a cluttered drawing) and ask the patient to describe it as a whole - they report only isolated fragments ("misses the forest for the trees"). Modified letter-cancellation test: oversized targets mixed with small foils - patients characteristically miss the larger targets because identifying them requires integrating information across multiple fixationsAsk the patient to reach for or point at an object (e.g., examiner's finger) presented in different parts of the visual field - reaching is inaccurate/misdirected, especially in peripheral vision
Key distinguishing maneuverTest with static perception/description tasks (naming objects, describing a scene) rather than motor reachingTest with proprioceptive- or auditory-guided reaching as a control: in optic ataxia, reaching guided by touch or sound (eyes closed) is intact, and once the patient's hand contacts the object, subsequent movements become smooth. This isolates the deficit to the visual-to-motor transformation pathway, not general motor/cerebellar control
Differentiator from cerebellar ataxiaNot applicable (simultanagnosia isn't a motor disorder)Optic ataxia is specifically dissociated from cerebellar ataxia by this proprioceptive/auditory-cue test - cerebellar ataxia impairs reaching regardless of sensory guidance, while optic ataxia only impairs visually-directed reaching
Underlying pathwayDisruption of visual-spatial "binding"/attention allocation across the visual fieldDisruption of transmission of visual information to the motor system for directing reaching movements (dorsal "where/how" stream to premotor cortex)
Can occur in isolation?Yes - especially in posterior cortical atrophy (up to 88% of cases), without optic ataxia or ocular apraxiaYes - can occur as a "pure" form even with a unilateral posterior parietal lesion, unlike simultanagnosia which typically requires bilateral damage
Practical bedside summary:
  • Ask the patient to describe a complex scene → fragmented, piecemeal description = simultanagnosia.
  • Ask the patient to reach and touch an object presented visually, then repeat with eyes closed using touch/sound cues → visually-guided reaching is clumsy/misdirected but touch-guided reaching is normal = optic ataxia.
Both may coexist with ocular (oculomotor) apraxia (impaired voluntary saccades) to complete the full Balint triad, so it's worth testing voluntary eye movements separately as well to determine which component(s) are present - partial Balint syndromes (isolated simultanagnosia or isolated optic ataxia) are well documented.
Sources: Neuroanatomy through Clinical Cases, 3rd ed.; Bradley and Daroff's Neurology in Clinical Practice; Kanski's Clinical Ophthalmology, 10th ed.; Localization in Clinical Neurology, 8th ed.

Write down the long answer type Notes on Colour percecption of eye, it's anatomical location, clinical importance

Finding Sources
Finding Sources
Finding Sources
Searching Images

retina cone photoreceptors trichromatic colour vision diagram

Searching Images

Ishihara colour blindness test plate

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

Write down the long answer type Notes on Colour percecption of eye, it's anatomical location, clinical importance

Finding Sources
Finding Sources
Searching PubMed

color vision deficiency AND diagnosis

Colour Perception of the Eye: Anatomy, Physiology and Clinical Importance

1. Introduction

Colour vision is the capacity to discriminate light of different wavelengths as different hues. It depends on a three-stage system: (1) wavelength-selective photoreceptors in the retina, (2) neural "colour-opponent" processing in the retina, lateral geniculate nucleus (LGN) and visual cortex, and (3) higher cortical integration in extrastriate areas that generates conscious colour perception. Disruption at any of these levels produces a distinct clinical picture, which is why colour vision testing has diagnostic value across ophthalmology, neurology and even systemic medicine.

2. Anatomical Location and Pathway of Colour Perception

A. Retina - the receptor level

  • Photoreceptors: Colour vision is mediated by cone photoreceptors, concentrated maximally in the fovea/macula (rods dominate the peripheral retina and are colour-blind).
  • Three cone types, each containing a different photopigment (a combination of retinal + a specific opsin, called photopsin):
    • S-cones (short-wave/"blue") - peak sensitivity ~430-445 nm
    • M-cones (middle-wave/"green") - peak sensitivity ~530-535 nm
    • L-cones (long-wave/"red") - peak sensitivity ~560-570 nm
  • Genetics: The red (L) and green (M) opsin genes lie adjacent to each other on the X chromosome (hence X-linked red-green colour blindness); the blue (S) opsin gene is on chromosome 7 (autosomal, so tritan defects are rare and non-sex-linked).
  • Retinal processing: Cone signals are relayed through bipolar cells to retinal ganglion cells, many of which are "colour-opponent" cells - excited by one colour and inhibited by its "opponent" colour (e.g., red-ON/green-OFF). Colour analysis therefore begins in the retina, not just the cortex.

B. Optic nerve, chiasm and tract

Colour-coded signals travel via small-diameter (parvocellular-destined) retinal ganglion cell axons in the optic nerve → optic chiasm (nasal fibres decussate) → optic tract. These fine-caliber fibres are particularly vulnerable to compressive and inflammatory optic neuropathies, which is why colour vision is often affected early in optic nerve disease.

C. Lateral Geniculate Nucleus (LGN), thalamus

  • The parvocellular (P) layers (layers 3-6) of the LGN carry the red-green opponent signal along with fine spatial detail.
  • Koniocellular (interlaminar) neurons, situated between the LGN laminae, carry the blue-yellow opponent signal.
  • The magnocellular pathway (layers 1-2) carries luminance/motion information and contributes little to colour.

D. Primary visual cortex (V1, striate cortex, Brodmann area 17)

  • Parvocellular and koniocellular inputs terminate in cytochrome-oxidase-rich "blobs" in layers 2/3 and in the deep part of layer 4C of V1.
  • Here, red-green, blue-yellow, and luminance channels first interact to create early colour-opponent cortical cells.

E. Extrastriate cortex - the "colour centre" (V4/V8)

  • From V1 blobs, colour information projects to V2 and then to V4 (and the human homologue sometimes termed V8), located in the ventral occipito-temporal cortex (fusiform and lingual gyri, supplied by the posterior cerebral artery).
  • This region is regarded as the region "uniquely concerned with colour vision" in humans - it converts opponent-channel signals into the subjective sensation of hue, though the exact mechanism of this final conversion is not fully understood.
  • Because this area lies close to face-processing regions (fusiform gyrus), bilateral lesions here frequently produce combined achromatopsia and prosopagnosia.

3. Physiological Theories of Colour Vision

  1. Young-Helmholtz Trichromatic Theory (retinal level): Colour sensation is determined by the relative firing rates of the three cone types. Any spectral colour (and even white) can be reproduced by mixing red, green and blue light in the correct proportions - the basis of trichromatic colour matching and colour television/display technology.
  2. Hering's Opponent-Process Theory (ganglion cell → LGN → cortex level): Colours are encoded as three opponent channels:
    • Red vs Green (L minus M cone signal)
    • Blue vs Yellow (S cone vs L+M combined signal)
    • Black vs White/luminance (L+M summed signal)
    This explains why we never perceive a colour as "reddish-green" or "bluish-yellow" simultaneously, and why staring at one colour produces an afterimage in its opponent colour.
Both theories are correct at different stages of the pathway - trichromacy operates in the retina, and opponency operates from the ganglion cell onward.

4. Clinical Importance

A. Clinical testing of colour vision

TestPrincipleUse
Ishihara platesNumbers/shapes embedded in coloured dot patterns designed to be indistinguishable to red-green defective observersRapid screening for congenital protan/deutan defects; also used to screen for acquired (optic nerve) defects
City University testSubject matches a central colour to one of four peripheral coloursScreening
Hardy-Rand-Rittler (HRR)Similar to Ishihara but detects all three axes (protan, deutan, and tritan)More complete congenital screening
Farnsworth-Munsell 100-Hue testSubject arranges coloured caps in hue sequenceSensitive, quantifies severity of both congenital and acquired defects, tracks disease over time
Inability to read even the control/demonstration plate (with adequate visual acuity) suggests non-organic (functional) visual loss.

B. Congenital colour vision deficiency (CVD)

  • Prevalence: ~8% of men, ~0.4-0.5% of women (Northern European populations); lower in other ethnic groups.
  • Inheritance: X-linked recessive (red and green opsin genes) → affects males; females are usually carriers, and X-linked colour blindness classically "skips a generation," appearing in males of every second generation. Tritan (blue) defects are autosomal and rare, without sex predilection.
  • Classification by cone number/function:
    • Trichromats - all 3 cone types functioning normally
    • Anomalous trichromats - all 3 cone types present, but one has a shifted spectral sensitivity (most common; mild colour confusion, normal visual acuity)
    • Dichromats - only 2 functional cone types (protanopia, deuteranopia, tritanopia - true "colour blindness" for that axis)
    • Monochromats - only 1 (or no) functional cone system; severe, often with reduced acuity
  • Terminology: prot- = red defect, deuter- = green defect, trit- = blue defect (e.g., protanomaly = red weakness, protanopia = red blindness).
  • Congenital defects classically spare the blue-yellow axis (protan/deutan predominate); acquired defects more often disrupt all colours or the blue-yellow axis preferentially.

C. Congenital achromatopsia (complete/incomplete)

  • Rod monochromatism (complete achromatopsia, autosomal recessive): total absence of colour vision (everything grey), poor acuity (~6/60), congenital nystagmus, photophobia, and hemeralopia (worse vision in bright light because rods saturate).
  • Blue-cone monochromatism (X-linked, incomplete achromatopsia): near-normal acuity but complete loss of colour discrimination.
  • Molecular basis: mutations in the cone-specific cyclic nucleotide-gated channel subunits CNGB3 (~50%) and CNGA3 (~25%); gene therapy restoring cone function has shown promise in animal models.

D. Acquired colour vision defects (important diagnostic clues)

  • Optic neuropathy (optic neuritis, compressive lesions, toxic/nutritional, glaucoma, ethambutol toxicity): produces red-green desaturation, often noticed by the patient before acuity is affected and persisting after acuity recovers - a sensitive marker of subclinical optic nerve dysfunction.
  • Macular/retinal disease (e.g., age-related macular degeneration, retinal dystrophies): tends to cause blue-yellow (tritan-type) defects, and dyschromatopsia may precede loss of acuity or visual field changes in retinal dystrophies.
  • Drug-induced:
    • Sildenafil (Viagra) - transient blue-green colour weakness from inhibition of retinal phosphodiesterase (PDE6, homologous to the penile PDE5 target).
    • Digoxin/digitalis toxicity - classically causes xanthopsia (yellow-tinted vision) and can affect colour perception generally.
    • Ethambutol, chloroquine/hydroxychloroquine - optic/retinal toxicity with colour vision changes (used clinically to monitor for toxicity).

E. Cerebral (cortical) achromatopsia

  • Caused by bilateral lesions of the ventral occipital/occipito-temporal cortex (lingual and fusiform gyri, V4/V8 territory), most often from bilateral posterior cerebral artery infarction, but also seen with tumour, trauma, or as part of posterior cortical atrophy.
  • Patients perceive the world only in shades of grey; the retina and optic nerves are structurally normal (differentiating it from ocular disease).
  • Frequently coexists with prosopagnosia (face blindness) because of the anatomical proximity of colour- and face-processing regions in the fusiform gyrus.
  • Colour anomia: infarcts of the dominant (usually left) occipital lobe can produce a dissociation where the patient can discriminate colours normally but cannot name them - a language-perception dissociation distinct from true achromatopsia.
  • Cerebral achromatopsia may also be a presenting feature of degenerative disease (posterior cortical atrophy) and is classically grouped with other "ventral stream" visual agnosias (object agnosia, prosopagnosia, pure alexia).

F. Practical/occupational relevance

  • Congenital CVD affects tasks such as distinguishing traffic-light colours (patients often learn to use light position rather than colour as a cue), colour-coded wiring, colour-coded maps/charts, and certain professions (pilots, electricians, some armed-forces roles, medical fields requiring colour-coded diagnostics e.g., dipstick urinalysis or histology). Early identification in children allows appropriate career counselling.
  • In clinical practice, colour vision testing is a quick, inexpensive bedside/office tool that can localize a lesion (retina vs macula vs optic nerve vs cortex) based on the pattern of colour loss (red-green vs blue-yellow vs global), and can monitor progression or toxicity in chronic optic and retinal disease.

5. Summary Table: Localizing Colour Vision Defects

Site of lesionTypical colour defectAssociated features
Cone photoreceptors (congenital)Red-green (protan/deutan) or blue-yellow (tritan)Normal or near-normal acuity, lifelong, X-linked (red-green)
Cone dystrophy/rod monochromatismGlobal/complete achromatopsiaPoor acuity, nystagmus, photophobia
Macula/retina (acquired)Blue-yellow predominantCentral scotoma, metamorphopsia
Optic nerve (optic neuritis, toxic, compressive)Red-green predominantReduced acuity, relative afferent pupillary defect, desaturation often out of proportion to acuity
Bilateral ventral occipital cortex (V4/V8)Complete cerebral achromatopsia (grey-scale vision)Prosopagnosia, normal fundus, homonymous field defects
Dominant occipital lobe (language areas)Colour anomia (naming defect only)Colour discrimination intact

Sources: Guyton and Hall Textbook of Medical Physiology; Ganong's Review of Medical Physiology, 26th ed.; Harrison's Principles of Internal Medicine, 22nd ed.; Adams and Victor's Principles of Neurology, 12th ed.; Kanski's Clinical Ophthalmology, 10th ed.; Neuroanatomy through Clinical Cases, 3rd ed.; Neuroscience: Exploring the Brain, 5th ed.
This is a shared conversation. Sign in to Orris to start your own chat.